• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结合树脂酸和金刚烷部分的新型酪氨酰-DNA磷酸二酯酶1(TDP1)抑制剂的设计、合成及分子对接研究

Design, Synthesis, and Molecular Docking Study of New Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors Combining Resin Acids and Adamantane Moieties.

作者信息

Kovaleva Kseniya, Yarovaya Olga, Ponomarev Konstantin, Cheresiz Sergey, Azimirad Amirhossein, Chernyshova Irina, Zakharenko Alexandra, Konev Vasily, Khlebnikova Tatiana, Mozhaytsev Evgenii, Suslov Evgenii, Nilov Dmitry, Švedas Vytas, Pokrovsky Andrey, Lavrik Olga, Salakhutdinov Nariman

机构信息

N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, Lavrentiev Ave. 9, 630090 Novosibirsk, Russia.

V. Zelman Institute for the Medicine and Psychology, Novosibirsk State University, Pirogova St. 1, 630090 Novosibirsk, Russia.

出版信息

Pharmaceuticals (Basel). 2021 May 1;14(5):422. doi: 10.3390/ph14050422.

DOI:10.3390/ph14050422
PMID:34062881
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8147275/
Abstract

In this paper, a series of novel abietyl and dehydroabietyl ureas, thioureas, amides, and thioamides bearing adamantane moieties were designed, synthesized, and evaluated for their inhibitory activities against tyrosil-DNA-phosphodiesterase 1 (TDP1). The synthesized compounds were able to inhibit TDP1 at micromolar concentrations (0.19-2.3 µM) and demonstrated low cytotoxicity in the T98G glioma cell line. The effect of the terpene fragment, the linker structure, and the adamantane residue on the biological properties of the new compounds was investigated. Based on molecular docking results, we suppose that adamantane derivatives of resin acids bind to the TDP1 covalent intermediate, forming a hydrogen bond with Ser463 and hydrophobic contacts with the Phe259 and Trp590 residues and the oligonucleotide fragment of the substrate.

摘要

本文设计、合成了一系列带有金刚烷部分的新型枞酰基和脱氢枞酰基脲、硫脲、酰胺及硫代酰胺,并对其酪氨酸-DNA-磷酸二酯酶1(TDP1)抑制活性进行了评估。合成的化合物能够在微摩尔浓度(0.19 - 2.3 μM)下抑制TDP1,并在T98G胶质瘤细胞系中表现出低细胞毒性。研究了萜烯片段、连接结构和金刚烷残基对新化合物生物学性质的影响。基于分子对接结果,我们推测树脂酸的金刚烷衍生物与TDP1共价中间体结合,与Ser463形成氢键,并与Phe259、Trp590残基以及底物的寡核苷酸片段形成疏水相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17df/8147275/57fdae19241f/pharmaceuticals-14-00422-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17df/8147275/23ddbbc4ac64/pharmaceuticals-14-00422-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17df/8147275/bc7069c2154f/pharmaceuticals-14-00422-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17df/8147275/a34b77ca3654/pharmaceuticals-14-00422-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17df/8147275/0391e46b4980/pharmaceuticals-14-00422-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17df/8147275/62d789508f15/pharmaceuticals-14-00422-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17df/8147275/76aaf1fe1ac5/pharmaceuticals-14-00422-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17df/8147275/57fdae19241f/pharmaceuticals-14-00422-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17df/8147275/23ddbbc4ac64/pharmaceuticals-14-00422-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17df/8147275/bc7069c2154f/pharmaceuticals-14-00422-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17df/8147275/a34b77ca3654/pharmaceuticals-14-00422-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17df/8147275/0391e46b4980/pharmaceuticals-14-00422-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17df/8147275/62d789508f15/pharmaceuticals-14-00422-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17df/8147275/76aaf1fe1ac5/pharmaceuticals-14-00422-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17df/8147275/57fdae19241f/pharmaceuticals-14-00422-g006.jpg

相似文献

1
Design, Synthesis, and Molecular Docking Study of New Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors Combining Resin Acids and Adamantane Moieties.结合树脂酸和金刚烷部分的新型酪氨酰-DNA磷酸二酯酶1(TDP1)抑制剂的设计、合成及分子对接研究
Pharmaceuticals (Basel). 2021 May 1;14(5):422. doi: 10.3390/ph14050422.
2
Novel Inhibitors of DNA Repair Enzyme TDP1 Combining Monoterpenoid and Adamantane Fragments.新型 DNA 修复酶 TDP1 的抑制剂,结合了单萜和金刚烷片段。
Anticancer Agents Med Chem. 2019;19(4):463-472. doi: 10.2174/1871520619666181207094243.
3
Novel Tdp1 Inhibitors Based on Adamantane Connected with Monoterpene Moieties via Heterocyclic Fragments.基于金刚烷连接的单萜类化合物通过杂环片段的新型 Tdp1 抑制剂。
Molecules. 2021 May 24;26(11):3128. doi: 10.3390/molecules26113128.
4
Adamantane-Monoterpenoid Conjugates Linked via Heterocyclic Linkers Enhance the Cytotoxic Effect of Topotecan.通过杂环连接子连接的金刚烷-单萜化合物增强拓扑替康的细胞毒性作用。
Molecules. 2022 May 24;27(11):3374. doi: 10.3390/molecules27113374.
5
New Dual Inhibitors of Tyrosyl-DNA Phosphodiesterase 1 and 2 Based on Deoxycholic Acid: Design, Synthesis, Cytotoxicity, and Molecular Modeling.新型基于脱氧胆酸的酪氨酸-DNA 磷酸二酯酶 1 和 2 双重抑制剂:设计、合成、细胞毒性和分子模拟。
Molecules. 2024 Jan 24;29(3):581. doi: 10.3390/molecules29030581.
6
Dehydroabietylamine Ureas and Thioureas as Tyrosyl-DNA Phosphodiesterase 1 Inhibitors That Enhance the Antitumor Effect of Temozolomide on Glioblastoma Cells.去氢枞胺脲和硫脲作为酪氨酰-DNA 磷酸二酯酶 1 抑制剂,增强替莫唑胺对神经胶质瘤细胞的抗肿瘤作用。
J Nat Prod. 2019 Sep 27;82(9):2443-2450. doi: 10.1021/acs.jnatprod.8b01095. Epub 2019 Aug 20.
7
The First Berberine-Based Inhibitors of Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), an Important DNA Repair Enzyme.首个基于黄连素的酪氨酰 DNA 磷酸二酯酶 1(Tdp1)抑制剂,一种重要的 DNA 修复酶。
Int J Mol Sci. 2020 Sep 28;21(19):7162. doi: 10.3390/ijms21197162.
8
Identification of novel inhibitors for the tyrosyl-DNA-phosphodiesterase 1 (Tdp1) mutant SCAN1 using virtual screening.利用虚拟筛选技术鉴定新型酪氨酸-DNA-磷酸二酯酶 1(Tdp1)突变体 SCAN1 的抑制剂。
Bioorg Med Chem. 2020 Jan 1;28(1):115234. doi: 10.1016/j.bmc.2019.115234. Epub 2019 Nov 30.
9
New Hybrid Compounds Combining Fragments of Usnic Acid and Monoterpenoids for Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibition.新型乌苏烷酸和单萜类化合物杂合化合物可有效抑制酪氨酰 DNA 磷酸二酯酶 1
Biomolecules. 2021 Jul 1;11(7):973. doi: 10.3390/biom11070973.
10
[Inhibitory Properties of Nitrogen-Containing Adamantane Derivatives with Monoterpenoid Fragments Against Tyrosyl-DNA Phosphodiesterase I].含单萜片段的氮杂金刚烷衍生物对酪氨酰-DNA磷酸二酯酶I的抑制特性
Bioorg Khim. 2015 Nov-Dec;41(6):731-6. doi: 10.1134/s1068162015060199.

引用本文的文献

1
Antibacterial and Anticandidal Activity of the Nanostructural Composite of a Spirothiazolidine-Derivative Assembled on Silver Nanoparticles.银纳米粒子组装的螺噻唑烷衍生物纳米结构复合材料的抗菌和抗真菌活性。
Molecules. 2024 Mar 4;29(5):1139. doi: 10.3390/molecules29051139.
2
Natural Products and Their Derivatives as Inhibitors of the DNA Repair Enzyme Tyrosyl-DNA Phosphodiesterase 1.天然产物及其衍生物作为 DNA 修复酶酪氨酰-DNA 磷酸二酯酶 1 的抑制剂。
Int J Mol Sci. 2023 Mar 17;24(6):5781. doi: 10.3390/ijms24065781.
3
Novel TDP1 Inhibitors: Disubstituted Thiazolidine-2,4-Diones Containing Monoterpene Moieties.

本文引用的文献

1
New Insights into the Binding Features of F508del CFTR Potentiators: A Molecular Docking, Pharmacophore Mapping and QSAR Analysis Approach.F508del型囊性纤维化跨膜传导调节因子增强剂结合特性的新见解:分子对接、药效团映射和定量构效关系分析方法
Pharmaceuticals (Basel). 2020 Dec 4;13(12):445. doi: 10.3390/ph13120445.
2
Deoxycholic acid as a molecular scaffold for tyrosyl-DNA phosphodiesterase 1 inhibition: A synthesis, structure-activity relationship and molecular modeling study.去氧胆酸作为酪氨酸-DNA 磷酸二酯酶 1 抑制剂的分子支架:合成、构效关系和分子模拟研究。
Steroids. 2021 Jan;165:108771. doi: 10.1016/j.steroids.2020.108771. Epub 2020 Nov 19.
3
新型 TDP1 抑制剂:含单萜部分的二取代噻唑烷-2,4-二酮。
Int J Mol Sci. 2023 Feb 14;24(4):3834. doi: 10.3390/ijms24043834.
4
Special Issue "Anticancer Drugs 2021".特刊“2021年抗癌药物”。
Pharmaceuticals (Basel). 2022 Apr 14;15(4):479. doi: 10.3390/ph15040479.
Multiple Topoisomerase I (TopoI), Topoisomerase II (TopoII) and Tyrosyl-DNA Phosphodiesterase (TDP) inhibitors in the development of anticancer drugs.
多种拓扑异构酶 I(TopoI)、拓扑异构酶 II(TopoII)和酪氨酰-DNA 磷酸二酯酶(TDP)抑制剂在抗癌药物的开发中的应用。
Eur J Pharm Sci. 2021 Jan 1;156:105594. doi: 10.1016/j.ejps.2020.105594. Epub 2020 Oct 12.
4
DNA topoisomerases as molecular targets for anticancer drugs.DNA 拓扑异构酶作为抗癌药物的分子靶点。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1781-1799. doi: 10.1080/14756366.2020.1821676.
5
Dehydroabietylamine-based thiazolidin-4-ones and 2-thioxoimidazolidin-4-ones as novel tyrosyl-DNA phosphodiesterase 1 inhibitors.基于去氢枞胺的噻唑烷-4-酮和 2-硫代亚氨唑烷-4-酮类化合物作为新型酪氨酰 DNA 磷酸二酯酶 1 抑制剂。
Mol Divers. 2021 Nov;25(4):2389-2397. doi: 10.1007/s11030-020-10132-z. Epub 2020 Aug 24.
6
Inhibition of Tyrosyl-DNA Phosphodiesterase 1 by Lipophilic Pyrimidine Nucleosides.脂溶性嘧啶核苷对酪氨酰-DNA 磷酸二酯酶 1 的抑制作用。
Molecules. 2020 Aug 13;25(16):3694. doi: 10.3390/molecules25163694.
7
Usnic Acid Conjugates with Monoterpenoids as Potent Tyrosyl-DNA Phosphodiesterase 1 Inhibitors.松萝酸与单萜类化合物的缀合物作为有效的酪氨酰-DNA 磷酸二酯酶 1 抑制剂。
J Nat Prod. 2020 Aug 28;83(8):2320-2329. doi: 10.1021/acs.jnatprod.9b01089. Epub 2020 Jul 28.
8
Synthesis and Biological Evaluation of Novel (thio)semicarbazone-Based Benzimidazoles as Antiviral Agents against Human Respiratory Viruses.新型(硫代)缩氨基脲基苯并咪唑类化合物的合成及抗人类呼吸道病毒活性评价。
Molecules. 2020 Mar 25;25(7):1487. doi: 10.3390/molecules25071487.
9
Promising New Inhibitors of Tyrosyl-DNA Phosphodiesterase I (Tdp 1) Combining 4-Arylcoumarin and Monoterpenoid Moieties as Components of Complex Antitumor Therapy.具有发展前景的新型酪氨酰 DNA 磷酸二酯酶 I(Tdp1)抑制剂,将 4-芳基香豆素和单萜类部分结合作为复杂抗肿瘤治疗的组成部分。
Int J Mol Sci. 2019 Dec 23;21(1):126. doi: 10.3390/ijms21010126.
10
Synthesis and biological evaluation of novel -(piperazin-1-yl)alkyl-1-dibenzo[,]carbazole derivatives of dehydroabietic acid as potential MEK inhibitors.新型去氢枞酸-(哌嗪-1-基)烷基-1-二苯并[,]咔唑衍生物的合成及作为潜在 MEK 抑制剂的生物评价。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):1544-1561. doi: 10.1080/14756366.2019.1655407.